Little-known Triangle company acquired for $525 million
An obscure pharmaceutical company with ties to the Triangle and Cayman Islands is being sold to a public company that wants its ADHD drug.
An obscure pharmaceutical company with ties to the Triangle and Cayman Islands is being sold to a public company that wants its ADHD drug.